ProVen Health VCT sells its investment in Onyx Scientific
ProVen Health VCT, managed by Beringea LLP, has sold its investment in Onyx Scientific in a transaction that valued the company at GBP4.6m. Onyx Scientific provides a wide range of chemical services to the life sciences industry. In particular, its key focus is scaling up the synthesis of new

